Impact of early changes in serum biomarkers following androgen deprivation therapy on clinical outcomes in metastatic hormone-sensitive prostate cancer

BACKGROUND: Less evidence is known about the role of early changes in serum biomarker after androgen deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). Here we evaluated the impact of pre-treatment prognostic factors and early changes in serum biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Hiromi, Narita, Shintaro, Tsuchiya, Norihiko, Koizumi, Atsushi, Nara, Taketoshi, Kanda, Sohei, Numakura, Kazuyuki, Tsuruta, Hiroshi, Maeno, Atsushi, Saito, Mitsuru, Inoue, Takamitsu, Satoh, Shigeru, Nomura, Kyoko, Habuchi, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941329/
https://www.ncbi.nlm.nih.gov/pubmed/29739368
http://dx.doi.org/10.1186/s12894-018-0353-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941329/
https://www.ncbi.nlm.nih.gov/pubmed/29739368
http://dx.doi.org/10.1186/s12894-018-0353-4

Ejemplares similares